ChemPartner
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A full-service CRO providing integrated drug discovery and development support for small molecules, biologics, and cell/gene therapies.
Technology Platform
Provides a comprehensive suite of integrated drug discovery and development technologies and services across small molecules, biologics, and advanced therapies.
Opportunities
Continued growth in global biopharma R&D spending and the trend towards outsourcing complex development work, especially in biologics and cell/gene therapy.
Risk Factors
Geopolitical tensions affecting cross-border collaboration and intense price competition in the CRO industry pressuring margins.
Competitive Landscape
Competes with large global CROs (e.g., WuXi AppTec, LabCorp) and other regional players on scale, service breadth, and cost-effectiveness.